Growth suppressive cytokines and the AKT/mTOR pathway

Cytokine

Volumn 48, Issue 1-2, 2009, Pages 138-143

  Kroczynska, Barbara ^a   Kaur, Surinder ^a   Platanias, Leonidas C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Interferon; mRNA; mTOR; Signaling; TNF

Indexed keywords

CYTOKINE; INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; INTERFERONS; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INTERFERON ALPHA-BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

MAMMALIA;

EID: 70349194381     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.07.009     Document Type: Review

References (63)

1. Baker SJ, Rane SG, Reddy EP. Hematopoietic cytokine receptor signaling. Oncogene 2007;26:6724-37.
2. Redig A.J., and Platanias L.C. The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis. J Interferon Cytokine Res 27 (2007) 623-636
3. Platanias L.C. Map kinase signaling pathways and hematologic malignancies. Blood 101 (2003) 4667-4679
4. Secchiero P., and Zauli G. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. Curr Opin Hematol 15 (2008) 42-48
5. Platanias L.C., and Fish E.N. Signaling pathways activated by interferons. Exp Hematol 27 (1999) 1583-1592
6. Isufi I., Seetharam M., Zhou L., Sohal D., Opalinska J., Pahanish P., et al. Transforming growth factor-beta signaling in normal and malignant hematopoiesis. J Interferon Cytokine Res 27 (2007) 543-552
7. Miranda M.B., and Johnson D.E. Signal transduction pathways that contribute to myeloid differentiation. Leukemia 21 (2007) 1363-1377
8. Darnell Jr. J.E. Stats and gene regulation. Science 277 (1997) 630-1635
9. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat Rev Immunol 5 (2005) 375-386
10. Aaronson D.S., and Horvath C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655
11. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., and Screiber R.D. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
12. Hay N. The AKT-mTOR tango and its relevance to cancer. Cancer Cell 8 (2005) 179-183
13. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Gen Dev 18 (2004) 1926-1945
14. Richter J.D., and Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433 (2005) 477-480
15. Dowling R.J., Pollak M., and Sonenberg N. Current status and challenges associated with targeting mTOR for cancer therapy. BioDrugs 23 (2009) 77-91
16. Konings I.R., Verweij J., Wiemer E.A., and Sleijfer S. The applicability of mTOR inhibition in solid tumors. Curr Cancer Drug Targets 9 (2009) 439-450
17. Mahalingam D., Sankhala K., Mita A., Giles F.J., and Mita M.M. Targeting the mTOR pathway using deforolimus in cancer therapy. Future Oncol 5 (2009) 291-303
18. Gingras A.C., Kennedy S.G., O'Leary M.A., Sonenberg N., and Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the AKT(PKB) signaling pathway. Genes Dev 12 (1998) 502-513
19. Gingras A.C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15 (2001) 2852-2864
20. Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H., Sherman N.E., and Pagano M. S6K1- and βTRCP-degradation of PDCD4 promotes protein translation and growth. Science 314 (2006) 467-471
21. Yang H.S., Jansen A.P., Komar A.A., Zheng Xm Lockett S.J., Sonenberg N., and Colburn N.H. The transformation suppressor Pdcd4 is a novel eIF4A binding protein that inhibits translation. Mol Cell Biol 23 (2003) 26-37
22. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
23. Deane J.A., and Fruman D.A. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 22 (2004) 563-598
24. Uddin S., Yenush L., Sun X.-J., Sweet M.E., White M.F., and Platanias L.C. Interferon α engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J Biol Chem 270 (1995) 15938-15941
25. Platanias L.C., Uddin S.C., Yetter A., Sun X., and White M.F. The Type I IFN receptor mediates tyrosine phosphorylation of insulin receptor substrate 2 (IRS2). J Biol Chem 271 (1996) 278-282
26. Uddin S., Fish E.N., Sher D.A., Gardziola C., White M.F., and Platanias L.C. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. J Immunol 158 (1997) 2390-2397
27. Burfoot M.S., Rogers N.C., Watling D., Smith J.M., Pons S., Paonessaw G., et al. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem 272 (1997) 24183-24190
28. Uddin S., Fish E.N., Sher D., Gardziola C., Colamonici O.R., Kellum M., et al. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors. Blood 90 (1997) 2574-2582
29. Lekmine F., Uddin S., Sassano A., Parmar S., Brachmann S.M., Majchrzak B., et al. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem 278 (2003) 27772-27780
30. Lekmine F., Sassano A., Uddin S., Smith J., Majchrzak B., Brachmann S.M., et al. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp Cell Res 295 (2004) 173-182
31. Kaur S., Lal L., Sassano A., Majchrzak-Kita B., Srikanth M., Baker D.P., et al. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J Biol Chem 282 (2007) 1757-1768
32. Kroczynska B., Kaur S., Katsoulidis E., Majchrzak-Kita B., Sassano A., Kozma S.C., et al. Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals. Mol Cell Biol 29 (2009) 2865-2875
33. Thyrell L., Hjortsberg L., Arulampalam V., Panaretakis T., Uhles S., Dagnell M., et al. Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J Biol Chem 279 (2004) 24152-24162
34. Kaur S., Sassano A., Dolniak B., Joshi S., Majchrzak-Kita B., Baker D.P., et al. Role of the AKT pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci USA 105 (2008) 4808-4813
35. Kaur S., Sassano A., Joseph A.M., Majchrzak-Kita B., Eklund E.A., Verma A., et al. Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J Immunol 181 (2008) 7316-7323
36. Matsumoto A, Ichikawa T, Nakao K, Miyaaki H, Hirano K, Fujimito M. Interferon-α-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-AKT-independent pathway. J Gastroenterol 19 May, 2009 [Epub ahead of print].
37. Fang P., Hwa V., and Rosenfeld R.G. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. Exp Cell Res 312 (2006) 1229-1239
38. Rosner D., Stoneman V., Littlewood T., McCarthy N., Figg N., Wang Y., et al. Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and AKT-dependent mechanism. Am J Pathol 168 (2006) 2054-2063
39. Colina R., Costa-Mattioli M., Dowling R.J., Jaramillo M., Tai L.H., Breitbach C.J., et al. Translational control of the innate immune response through IRF-7. Nature 452 (2008) 323-328
40. Kusaba H., Ghosh P., Derin R., Buchholz M., Sasaki C., Madara K., et al. Interleukin-12-induced interferon-gamma production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR). J Biol Chem 280 (2005) 1037-1043
41. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
42. Guo D., and Donner D.B. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271 (1996) 615-618
43. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., and Donner D.B. NF-kappaB activation by tumour necrosis factor requires the AKT serine-threonine kinase. Nature 401 (1999) 82-85
44. Gustin J.A., Maehama T., Dixon J.E., and Donner D.B. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. J Biol Chem 276 (2001) 27740-27744
45. Ozes O.N., Akca H., Mayo L.D., Gustin J.A., Maehama T., Dixon J.E., et al. A phosphatidylinositol 3-kinase/AKT/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci USA 98 (2001) 4640-4645
46. González-Rodriguez A, Alba J, Zimmerman V, Kozma SC, Valverde AM. S6K1 deficiency protects against apoptosis in hepatocytes. Hepatology 2009 February 18 [Epub ahead of print].
47. Lang C.H., and Frost R.A. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism 56 (2007) 49-57
48. Wang P., Wu P., Zhang J., Sato T., and Yamagata S. Yamagata T: positive regulation of tumor necrosis factor alpha by ganglioside GM3 through AKT in mouse melanoma B16 cells. Biochem Biophys Res Commun 356 (2007) 438-443
49. Wang P., Yang X., Wu P., Zhang J., Sato T., Yamagata S., et al. GM3 signals regulating TNF-alpha expression are mediated by Rictor and Arhgdib in mouse melanoma B16 cells. Oncology 73 (2007) 430-438
50. Qiu L., Zhang L., Zhu L., Yang D., Li Z., Qin K., et al. PI3K/AKT mediates expression of TNF-alpha mRNA and activation of NF-kappaB in calyculin A-treated primary osteoblasts. Oral Dis 14 (2008) 727-773
51. Granata F., Frattini A., Loffredo S., Del Prete A., Sozzani S., Marone G., et al. Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages. Eur J Immunol 36 (2006) 1938-1950
52. Patterson G.I., and Padgett R.W. TGF beta-related pathways. Roles in Caenorhabditis elegans development. Trends Genet 16 (2000) 27-33
53. Massagué J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1 (2000) 169-178
54. Massagué J. TGFbeta in cancer. Cell 134 (2008) 215-230
55. Wilkes M.C., Mitchell H., Penheiter S.G., Doré J.J., Suzuki K., Edens M., et al. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65 (2005) 10431-10440
56. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., and Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275 (2000) 36803-36810
57. Wilkes M.C., Edens M., Kottom T.J., Blenis J., and Leof E.B. Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta. Cancer Res 69 (2009) 84-93
58. Horowitz J.C., Lee D.Y., Waghray M., Keshamouni V.G., Thomas P.E., Zhang H., et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 279 (2004) 1359-1367
59. Zhu Y., Culmsee C., Klumpp S., and Krieglstein J. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/AKT and mitogen-activated protein kinase-extracellular-signal regulated kinase1, 2 signaling pathways. Neuroscience 123 (2004) 897-906
60. Terme JM, Lhermitte L, Asnafi V, Jalinot P. TGF-{beta} induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation. Blood 2009 [Epub ahead of print].
61. Qureshi H.Y., Ahmad R., Sylvester J., and Zafarullah M. Requirement of phosphatidylinositol 3-kinase/AKT signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cell Signal 19 (2007) 1643-1651
62. Gadir N., Jackson D.N., Lee E., and Foster D.A. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin. Oncogene 27 (2008) 1055-1062
63. Song K., Wang H., Krebs T.L., and Danielpour D. Novel roles of AKT and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J 25 (2006) 58-69